<?xml version="1.0" encoding="ISO-8859-1"?>
<rss version="2.0">
    <channel>
        <title>DSM Press Release Headlines</title>
        <link>http://www.dsm.com</link>
        <description>The latest corporate press releases from dsm.com</description>
        <language>en_US</language>
        <pubDate>05/13/2008 18:25:15</pubDate>
        <ttl>60</ttl>
        <lastBuildDate>05/13/2008 18:25:15</lastBuildDate>
        <item>
            <title>DSM - Repurchase of shares (week 19)</title>
            <link>http://www.dsm.com/en_US/html/media/press_releases/23_08_repurchase_shares_week_19.htm</link>
            <guid isPermaLink="false">http://www.dsm.com/en_US/html/media/press_releases/23_08_repurchase_shares_week_19.htm</guid>
            <description>

Royal DSM N.V. has repurchased 298,333 of its own shares in the period from 5 
May 2008 up to and including 7 May 2008 at an average price of EUR 35.46. This 
is in accordance with the second phase of the share buyback program, announced 
on 5 May 2008.

</description>
            <pubDate>09-May-2008 09:15 CET</pubDate>
        </item>
        <item>
            <title>DSM initiates second phase of share buy-back program</title>
            <link>http://www.dsm.com/en_US/html/media/press_releases/22_08_dsm_initiates_second_phase_share_buy_back_program.htm</link>
            <guid isPermaLink="false">http://www.dsm.com/en_US/html/media/press_releases/22_08_dsm_initiates_second_phase_share_buy_back_program.htm</guid>
            <description>

Royal DSM N.V., the global Life Sciences and Materials Sciences company 
headquartered in the Netherlands, announces that the company will today, 5 May 
2008, start the second phase of the share buy-back program of EUR 750 million 
announced on 27 September 2007.

</description>
            <pubDate>05-May-2008 08:15 CET</pubDate>
        </item>
        <item>
            <title>DSM expects record year following very strong first quarter</title>
            <link>http://www.dsm.com/en_US/html/media/press_releases/21_08_q1.htm</link>
            <guid isPermaLink="false">http://www.dsm.com/en_US/html/media/press_releases/21_08_q1.htm</guid>
            <description>

Organic sales growth 14% due to strong business positions and favorable market 
conditions. EBIT from continuing operations up 22% despite lower US dollar and 
higher feedstock prices. Earnings per share up 42%. Execution of Vision 2010 
strategy fully on track. Resumption of share buy-back program for next EUR 250 
million as of 5 May. Outlook: 2008 EBIT expected to be EUR 870 million +/- 5%.

</description>
            <pubDate>29-Apr-2008 08:15 CET</pubDate>
        </item>
        <item>
            <title>DSM acquires PTG to expand its fast growing biomedical materials business</title>
            <link>http://www.dsm.com/en_US/html/media/press_releases/20_08_dsm_acquires_ptg.htm</link>
            <guid isPermaLink="false">http://www.dsm.com/en_US/html/media/press_releases/20_08_dsm_acquires_ptg.htm</guid>
            <description>

Royal DSM N.V., the global Life Sciences and Materials Sciences company 
headquartered in the Netherlands, today announces an agreement to acquire The 
Polymer Technology Group, Inc. (PTG) of Berkeley (California, United States).

</description>
            <pubDate>28-Apr-2008 08:15 CET</pubDate>
        </item>
        <item>
            <title>DSM announces opening of PA4T market development plant</title>
            <link>http://www.dsm.com/en_US/html/media/press_releases/19_08_dsm_opening_PA4T_market_development_plant.htm</link>
            <guid isPermaLink="false">http://www.dsm.com/en_US/html/media/press_releases/19_08_dsm_opening_PA4T_market_development_plant.htm</guid>
            <description>

Royal DSM N.V., the global Life Sciences and Materials Sciences company 
headquartered in the Netherlands, today announced the opening of the market 
development plant for PA4T, the new polymer for use in electronics and other 
applications. The plant is operational as of today.

</description>
            <pubDate>25-Apr-2008 10:15 CET</pubDate>
        </item>
        <item>
            <title>DSM announces plans for largest investment program ever for DyneemaŽ</title>
            <link>http://www.dsm.com/en_US/html/media/press_releases/18_08_dsm_largest_investment_program_dyneema.htm</link>
            <guid isPermaLink="false">http://www.dsm.com/en_US/html/media/press_releases/18_08_dsm_largest_investment_program_dyneema.htm</guid>
            <description>

Royal DSM N.V., the global Life Sciences and Materials Sciences company 
headquartered in the Netherlands, today announces plans for a substantial 
capital expenditure program, expected to involve up to USD 450 million.

</description>
            <pubDate>17-Apr-2008 08:15 CET</pubDate>
        </item>
        <item>
            <title>DSM Management appointments</title>
            <link>http://www.dsm.com/en_US/html/media/press_releases/17_08_DSM_management_appointments.htm</link>
            <guid isPermaLink="false">http://www.dsm.com/en_US/html/media/press_releases/17_08_DSM_management_appointments.htm</guid>
            <description>

Royal DSM N.V. announces the following management appointments: Jos Goessens 
(1951), at present Business Group Director DSM Engineering Plastics, has been 
appointed Director Strategic Projects, reporting to the Managing Board. Roelof 
Westerbeek (1963) has been appointed Business Group Director DSM Engineering 
Plastics with effect from 1 October 2008.

</description>
            <pubDate>11-Apr-2008 14:15 CET</pubDate>
        </item>
        <item>
            <title>DSM provides 2007 comparative figures in line with new structure</title>
            <link>http://www.dsm.com/en_US/html/media/press_releases/16_08_dsm_2007_comparative_figures.htm</link>
            <guid isPermaLink="false">http://www.dsm.com/en_US/html/media/press_releases/16_08_dsm_2007_comparative_figures.htm</guid>
            <description>

Royal DSM N.V. today provides the investment community with comparative 
figures for 2007 that reflect the company&#8217;s new cluster structure as of 1 
January 2008. The new structure was announced in September 2007 and is a 
result of the acceleration of DSM&#8217;s strategy Vision 2010 &#8211; Building on 
Strengths.

</description>
            <pubDate>09-Apr-2008 08:15 CET</pubDate>
        </item>
        <item>
            <title>DSM announces good start to the year and raises expectations for full year 2008</title>
            <link>http://www.dsm.com/en_US/html/media/press_releases/13_08_dsm_trading_update.htm</link>
            <guid isPermaLink="false">http://www.dsm.com/en_US/html/media/press_releases/13_08_dsm_trading_update.htm</guid>
            <description>

At the Annual General Meeting being held later today, DSM will provide a 
trading update for 2008.

</description>
            <pubDate>26-Mar-2008 08:15 CET</pubDate>
        </item>
        <item>
            <title>Final dividend 2007 Royal DSM N.V.</title>
            <link>http://www.dsm.com/en_US/html/media/press_releases/15_08_final_dividend_2007_dsm.htm</link>
            <guid isPermaLink="false">http://www.dsm.com/en_US/html/media/press_releases/15_08_final_dividend_2007_dsm.htm</guid>
            <description>

The DSM Annual General Meeting of Shareholders on 26 March 2008 passed a 
resolution to declare a dividend for 2007 of EUR 1.20 per ordinary share of 
EUR 1.50 par value. An interim dividend of EUR 0.33 per ordinary share having 
been paid on 22 August 2007, the final dividend for 2007 will amount to EUR 
0.87 per ordinary share.

</description>
            <pubDate>26-Mar-2008 18:15 CET</pubDate>
        </item>
        <item>
            <title>DSM announces results of Annual General Meeting of Shareholders</title>
            <link>http://www.dsm.com/en_US/html/media/press_releases/14_08_dsm_announces_results_agm.htm</link>
            <guid isPermaLink="false">http://www.dsm.com/en_US/html/media/press_releases/14_08_dsm_announces_results_agm.htm</guid>
            <description>

Royal DSM N.V. today held its Annual General Meeting of Shareholders.

</description>
            <pubDate>26-Mar-2008 18:15 CET</pubDate>
        </item>
        <item>
            <title>DSM Triple P Report 2007: sustainability as a core element of company strategy</title>
            <link>http://www.dsm.com/en_US/html/media/press_releases/12_08_triple_p_report_2007.htm</link>
            <guid isPermaLink="false">http://www.dsm.com/en_US/html/media/press_releases/12_08_triple_p_report_2007.htm</guid>
            <description>

Royal DSM N.V. is today presenting its fifth annual sustainability report: the 
Triple P (People, Planet, Profit) Report 2007 entitled Embracing the Future.

</description>
            <pubDate>20-Mar-2008 08:15 CET</pubDate>
        </item>
        <item>
            <title>DSM invests in innovative treatment against infectious diseases</title>
            <link>http://www.dsm.com/en_US/html/media/press_releases/11_08_invests_innovative_treatment_infectious_diseases.htm</link>
            <guid isPermaLink="false">http://www.dsm.com/en_US/html/media/press_releases/11_08_invests_innovative_treatment_infectious_diseases.htm</guid>
            <description>

DSM Venturing, the corporate venturing unit of Royal DSM N.V., today announced 
that it has made an equity investment in the Dutch company IQ Therapeutics B.V.

</description>
            <pubDate>06-Mar-2008 08:15 CET</pubDate>
        </item>
        <item>
            <title>DSM invests in development of bio-based materials in China</title>
            <link>http://www.dsm.com/en_US/html/media/press_releases/10_08_dsm_invests_development_bio_based_materials_china.htm</link>
            <guid isPermaLink="false">http://www.dsm.com/en_US/html/media/press_releases/10_08_dsm_invests_development_bio_based_materials_china.htm</guid>
            <description>

DSM Venturing, the corporate venturing unit of Royal DSM N.V., today announced 
that it has participated in a USD 20 million financing round in Tianjin Green 
Bio-Science Co., Ltd (China).

</description>
            <pubDate>05-Mar-2008 08:15 CET</pubDate>
        </item>
        <item>
            <title>DSM intends to close Agro plant in IJmuiden (NL)</title>
            <link>http://www.dsm.com/en_US/html/media/press_releases/08_08_dsm_close_agro_plant_ijmuiden.htm</link>
            <guid isPermaLink="false">http://www.dsm.com/en_US/html/media/press_releases/08_08_dsm_close_agro_plant_ijmuiden.htm</guid>
            <description>

The Dutch Ministers Cramer (Housing, Spatial Planning and the Environment) and 
Eurlings (Transport, Public Works and Water Management) and DSM today announce 
that they have reached an agreement in principle on the termination of ammonia 
transport by rail between Geleen and IJmuiden.

</description>
            <pubDate>04-Mar-2008 07:15 CET</pubDate>
        </item>
        <item>
            <title>DSM and Dutch Olympic Committee present new Olympic boat</title>
            <link>http://www.dsm.com/en_US/html/media/press_releases/09_08_dsm_presents_olympic_470.htm</link>
            <guid isPermaLink="false">http://www.dsm.com/en_US/html/media/press_releases/09_08_dsm_presents_olympic_470.htm</guid>
            <description>

DSM, the innovative partner in sports of the Dutch Olympic Committee 
(NOC*NSF), is presenting a number of major innovations for the sport of sailing

</description>
            <pubDate>04-Mar-2008 11:15 CET</pubDate>
        </item>
        <item>
            <title>DSM to sell Special Products to Arsenal Capital as first divestment following accelerated Vision 2010</title>
            <link>http://www.dsm.com/en_US/html/media/press_releases/07_08_dsm_sell_special_products_arsenal_capital.htm</link>
            <guid isPermaLink="false">http://www.dsm.com/en_US/html/media/press_releases/07_08_dsm_sell_special_products_arsenal_capital.htm</guid>
            <description>

Royal DSM N.V., the global Life Sciences and Materials Sciences company 
headquartered in the Netherlands, has reached an agreement in principle with 
Arsenal Capital Partners (United States) on the sale of DSM Special Products 
BV. 

</description>
            <pubDate>03-Mar-2008 08:15 CET</pubDate>
        </item>
        <item>
            <title>DSM receives grant of US Department of Energy for biotechnology research </title>
            <link>http://www.dsm.com/en_US/html/media/press_releases/06_08_dsm_receives_grant_us_department_energy.htm</link>
            <guid isPermaLink="false">http://www.dsm.com/en_US/html/media/press_releases/06_08_dsm_receives_grant_us_department_energy.htm</guid>
            <description>

Royal DSM N.V., the global Life Sciences and Materials Sciences company 
headquartered in the Netherlands, has received a grant from the US Department 
of Energy for a technical consortium on an innovative biotechnological 
approach of bioproducts and biofuels.

</description>
            <pubDate>27-Feb-2008 08:15 CET</pubDate>
        </item>
        <item>
            <title>Proposed new member of Royal DSM N.V. Supervisory Board</title>
            <link>http://www.dsm.com/en_US/html/media/press_releases/05_08_proposed_new_member_DSM_supervisory_board_louise_gunning.htm</link>
            <guid isPermaLink="false">http://www.dsm.com/en_US/html/media/press_releases/05_08_proposed_new_member_DSM_supervisory_board_louise_gunning.htm</guid>
            <description>

DSM proposes appointing Mrs Louise Gunning-Schepers as a member of its 
Supervisory Board.

</description>
            <pubDate>25-Feb-2008 08:15 CET</pubDate>
        </item>
        <item>
            <title>DSM reports good Q4 2007 &#8211; Full year according to expectations</title>
            <link>http://www.dsm.com/en_US/html/media/press_releases/04_08_annual_results_2007.htm</link>
            <guid isPermaLink="false">http://www.dsm.com/en_US/html/media/press_releases/04_08_annual_results_2007.htm</guid>
            <description>

Strong Q4 results based on 10% organic sales growth. Operating profit for 2007 
of EUR 823 million in line with expectations. Net profit before exceptional 
items at EUR 558 million, better than last year; EPS 8% higher. Proposed 
dividend EUR 1.20 per ordinary share (+20%). Outlook: Operating profit before 
exceptional items in 2008 expected to approach level achieved in 2007.

</description>
            <pubDate>13-Feb-2008 08:15 CET</pubDate>
        </item>
    </channel>
</rss>
